Your browser doesn't support javascript.
loading
Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication.
Lu, Ming-Ying; Liu, Ta-Wei; Liang, Po-Cheng; Huang, Ching-I; Tsai, Yi-Shan; Tsai, Pei-Chien; Ko, Yu-Min; Wang, Wen-Hsuan; Lin, Ching-Chih; Chen, Kuan-Yu; Wang, Shu-Chi; Wei, Yu-Ju; Hsu, Po-Yao; Jang, Tyng-Yuan; Hsieh, Ming-Yen; Wang, Chih-Wen; Yeh, Ming-Lun; Lin, Zu-Yau; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung.
Afiliación
  • Lu MY; School of Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University Kaohsiung, Taiwan.
  • Liu TW; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Liang PC; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Huang CI; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Tsai YS; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Tsai PC; School of Medicine and Hepatitis Research Center, College of Medicine, Kaohsiung Medical University Kaohsiung, Taiwan.
  • Ko YM; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Kaohsiung, Taiwan.
  • Wang WH; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Lin CC; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Chen KY; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Wang SC; Department of Nursing, Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung, Taiwan.
  • Wei YJ; Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung, Taiwan.
  • Hsu PY; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Jang TY; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Hsieh MY; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University Kaohsiung, Taiwan.
  • Wang CW; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Yeh ML; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Lin ZY; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Huang CF; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Huang JF; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Dai CY; Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
  • Chuang WL; School of Medicine and Hepatitis Research Center, College of Medicine, Kaohsiung Medical University Kaohsiung, Taiwan.
  • Yu ML; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Kaohsiung, Taiwan.
Am J Cancer Res ; 13(1): 190-203, 2023.
Article en En | MEDLINE | ID: mdl-36777503
Successful eradication of the hepatitis C virus (HCV) cannot eliminate the risk of hepatocellular carcinoma (HCC). Next-generation RNA sequencing provides comprehensive genomic insights into the pathogenesis of HCC. Artificial intelligence has opened a new era in precision medicine. This study integrated clinical features and genetic biomarkers to establish a machine learning-based HCC model following viral eradication. A prospective cohort of 55 HCV patients with advanced fibrosis, who achieved a sustained virologic response after antiviral therapy, was enrolled. The primary outcome was the occurrence of HCC. The genomic signatures of peripheral blood mononuclear cells (PBMC) were determined by RNA sequencing at baseline and 24 weeks after end-of-treatment. Machine learning algorithms were implemented to extract the predictors of HCC. HCC occurred in 8 of the 55 patients, with an annual incidence of 2.7%. Pretreatment PBMC DEFA1B, HBG2, ADCY4, and posttreatment TAS1R3, ABCA3, and FOSL1 genes were significantly downregulated, while the pretreatment ANGPTL6 gene was significantly upregulated in the HCC group compared to that in the non-HCC group. A gene score derived from the result of the decision tree algorithm can identify HCC with an accuracy of 95.7%. Gene score = TAS1R3 (≥0.63 FPKM, yes/no = 0/1) + FOSL1 (≥0.27 FPKM, yes/no = 0/1) + ABCA3 (≥2.40 FPKM, yes/no = 0/1). Multivariate Cox regression analysis showed that this gene score was the most important predictor of HCC (hazard ratio = 2.38, 95% confidence interval [CI] = 1.06-5.36, P = 0.036). Combining the gene score and fibrosis-4 index, a nomogram was constructed to predict the probability of HCC with an area under the receiver operating characteristic curve up to 0.950 (95% CI = 0.888-1.000, P = 7.0 × 10-5). Decision curve analysis revealed that the nomogram had a net benefit in HCC detection. The calibration curve showed that the nomogram had optimal concordance between the predicted and actual HCC probabilities. In conclusion, down-regulated posttreatment PBMC TAS1R3, ABCA3, and FOSL1 expression were significantly correlated with HCC development after HCV eradication. Decision-tree-based algorithms can refine the assessment of HCC risk for personalized HCC surveillance.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos